Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

43.30 -0.55 (-1.24%)
Streaming Delayed Price Updated: 1:44 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 629,643
Open 43.96
Bid (Size) 43.22 (4)
Ask (Size) 43.39 (4)
Prev. Close 43.85
Today's Range 43.01 - 45.34
52wk Range 32.44 - 104.87
Shares Outstanding 78,684,039
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%
Cathie Wood is bullish about these stocks. And so are Wall Street analysts. 
Via The Motley Fool

Performance

YTD
+24.98%
+24.98%
1 Month
+19.00%
+19.00%
3 Month
-10.77%
-10.77%
6 Month
-31.79%
-31.79%
1 Year
-55.55%
-55.55%

More News

Read More
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
Via Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
Via InvestorPlace
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Expert Ratings for Intellia Therapeutics
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
The Latest Analyst Ratings for Intellia Therapeutics
Via Benzinga
Analyst Ratings for Intellia Therapeutics
Via Benzinga
Intellia's Hereditary Angioedema Candidate Shows Reduction In Associated Biomarkers, Attack Rates
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
Via Benzinga
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years
Via The Motley Fool
Recap: Intellia Therapeutics Q3 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
Via Benzinga
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
Via The Motley Fool
3 Mid-Caps That Could Double in 2023
Via MarketBeat
7 ‘Next Big Things’ for Investors to Buy for 2023
Via InvestorPlace
Ulta Beauty To Rally Around 22%? Here Are 10 Other Price Target Changes For Friday
Via Benzinga
NTLA Stock Falls as Intellia Therapeutics Announces Public Offering
Via InvestorPlace
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.